Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FLUDARABINE Cause Therapy partial responder? 122 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Therapy partial responder have been filed in association with FLUDARABINE (Fludarabine Phosphate). This represents 0.5% of all adverse event reports for FLUDARABINE.

122
Reports of Therapy partial responder with FLUDARABINE
0.5%
of all FLUDARABINE reports
30
Deaths
10
Hospitalizations

How Dangerous Is Therapy partial responder From FLUDARABINE?

Of the 122 reports, 30 (24.6%) resulted in death, 10 (8.2%) required hospitalization, and 3 (2.5%) were considered life-threatening.

Is Therapy partial responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FLUDARABINE. However, 122 reports have been filed with the FAERS database.

What Other Side Effects Does FLUDARABINE Cause?

Off label use (3,018) Febrile neutropenia (2,055) Drug ineffective (1,630) Pyrexia (1,606) Product use in unapproved indication (1,530) Cytokine release syndrome (1,458) Neutropenia (1,175) Cytomegalovirus infection (1,132) Mucosal inflammation (1,036) Sepsis (981)

What Other Drugs Cause Therapy partial responder?

CYCLOPHOSPHAMIDE (1,397) RITUXIMAB (1,219) DEXAMETHASONE (1,199) PREDNISONE (1,176) PEMBROLIZUMAB (1,125) CARBOPLATIN (1,096) DOXORUBICIN (834) METHOTREXATE (775) VINCRISTINE (707) ETOPOSIDE (670)

Which FLUDARABINE Alternatives Have Lower Therapy partial responder Risk?

FLUDARABINE vs FLUDEOXYGLUCOSE F-18 FLUDARABINE vs FLUDROCORTISONE FLUDARABINE vs FLUINDIONE FLUDARABINE vs FLUMAZENIL FLUDARABINE vs FLUMETHASONE

Related Pages

FLUDARABINE Full Profile All Therapy partial responder Reports All Drugs Causing Therapy partial responder FLUDARABINE Demographics